相关实验视频
Updated: Jan 13, 2026

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
20.1K
在怀孕期间治疗绝缘阻燃性心房动的管理
Faris Abu Za'nouneh1, Kevin Benavente1, Jadon Neuendorf1
1Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, 96813, Hawaii, USA.
Case reports in medicine
|January 8, 2026
概括
本案例研究突出了怀孕期间复发性心房 (AF) 的罕见情况,强调需要及时诊断和管理,以确保母亲和胎儿的福祉.
科学领域:
- 心脏病学 心脏病学
- 产科 产科 产科 产科 产科
- 药理学 药理学是指药理学的学科.
背景情况:
- 在怀孕期间,心房动不常见 (发病率为0.03%).
- 在怀孕期间具有结构正常的心脏的药物耐药性和切除耐药性AF异常罕见.
- 怀孕期间的AF由于血液动力学变化,对母亲和胎儿都有风险.
研究的目的:
- 在怀孕期间报告一种罕见的复发性心房动 (AF) 病例.
- 讨论在孕妇患者中管理药物耐药AF的挑战.
- 突出早期识别和治疗怀孕期AF的重要性.
主要方法:
- 一个35岁的孕妇 (19周怀孕) 的病例报告,患有复发性阴道发作性AF.
- 审查之前的AF管理,包括药物试验 (labetalol,verapamil,digoxin,flecainide) 和导管切除.
- 描述当前的怀孕表现,尽管增加了β-阻断剂剂量,但仍有昏迷和心.
主要成果:
- 患者在当前怀孕期间经历了复发的AF发作,对标准治疗调整没有反应.
- 以前的治疗包括弗莱卡尼德"口袋药"疗法和导管切除.
- 患者出现昏和心,表明需要进一步干预.
结论:
- 在怀孕期间治疗复发性,耐火性AF存在重大挑战.
- 在选择怀孕期间的AF治疗时,仔细考虑母亲和胎儿的安全至关重要.
- 这一案例凸显了在妊娠期内经过剥离的耐火性AF的罕见性和复杂性.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
424
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
424
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
453
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
453
Disturbances in Heart Rhythm
2.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.5K
Cardiopulmonary Resuscitation IV: Pharmacological Management
639
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
639
Mitral Valve Prolapse III: Nursing Management
279
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
279
Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K

